Page last updated: 2024-08-21

erythromycin and alatrofloxacin

erythromycin has been researched along with alatrofloxacin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Bermejo, M; García-de-Lomas, J; Gimeno, C; Lázaro, MA; Millás, E; Navarro, D; Sánchez, S	1

Other Studies

2 other study(ies) available for erythromycin and alatrofloxacin

Article	Year
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
A comparative study on the efficacy of the new quinolone alatrofloxacin in the treatment of experimental legionellosis in guinea pigs. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:6 Topics: Administration, Oral; Animals; Anti-Infective Agents; Drug Evaluation, Preclinical; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Guinea Pigs; Injections, Intraperitoneal; Legionella pneumophila; Legionnaires' Disease; Lung; Microbial Sensitivity Tests; Prodrugs; Random Allocation; Rifampin	1998

Article

Year

FDA-approved drug labeling for the study of drug-induced liver injury.

Drug discovery today, 2011, Volume: 16, Issue:15-16

Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011

A comparative study on the efficacy of the new quinolone alatrofloxacin in the treatment of experimental legionellosis in guinea pigs.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:6

Topics: Administration, Oral; Animals; Anti-Infective Agents; Drug Evaluation, Preclinical; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Guinea Pigs; Injections, Intraperitoneal; Legionella pneumophila; Legionnaires' Disease; Lung; Microbial Sensitivity Tests; Prodrugs; Random Allocation; Rifampin

1998